Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.


Bayer’s U.S. unit charged with sex discrimination

Six former and current employees of Bayer AG’s U.S. health care arm filed a $100 million gender discrimination lawsuit Monday, claiming the U.S. unit discriminates against its female employees in terms of pay and promotion, as well as pregnancy leave. Get the full story »

Bayer, J&J anti-clot drug shines in stroke trial

A once-daily pill being developed by Bayer AG and Johnson & Johnson was better at preventing stroke than standard treatment, with less risk of the most worrisome types of bleeding, researchers said on Monday. Get the full story »

Bayer, J&J blood pill shows mass-market promise

A new stroke prevention drug developed by Bayer and Johnson & Johnson proved a safe alternative to the standard treatment, lifting their chances of entering a $12 billion plus market, the German drug company said.

A late-stage study called Rocket-AF showed that the Xarelto pill was as good as the established warfarin pill at reducing the risk of strokes due to a form of irregular heartbeat that is common among the elderly, Bayer said on Sunday. Get the full story »

U.S. states settle with Bayer over vitamin claims

Attorneys general in Illinois, Oregon and California said on Tuesday that Bayer AG agreed to a $3.3 million settlement over misleading claims that the drug maker’s vitamins reduced men’s risk of prostate cancer.

Under the terms of the settlement, Bayer cannot make claims that its One A Day Men’s multivitamins can prevent or cure prostate cancer or any other disease without scientific evidence, Illinois Attorney General Lisa Madigan said in a statement.

“When manufacturers like Bayer make marketing claims with insufficient scientific proof behind them, they are misleading consumers,” she said. Get the full story »

FDA looks at regulating drug in cough medicine

Federal health regulators are weighing restrictions on Robitussin, NyQuil and other cough suppressants to curb abuse that sends thousands of people to the hospital each year.

The Food and Drug Administration on Tuesday posted its review of dextromethorphan, an ingredient in more than 100 over-the-counter medications that is sometimes abused for its euphoric effects. The practice, dubbed “robotripping,” involves taking more than 25 times the recommended dose of a cold medicine and is mainly associated with teenagers. Get the full story »

Bayer to phase out pesticide in use since 1970

A unit of Bayer AG is phasing out production of a pesticide used on numerous U.S. crops such as cotton, peanuts and potatoes now that the U.S. Environmental Protection Agency has found that the 40-year-old product doesn’t meet food safety rules.

In a release Tuesday, the EPA said new toxicity data show that the pesticide aldicarb –  marketed under the trade name Temik — no longer meets the agency’s safety standards. Get the full story »